Biotop-report 2014

24

BioTOPics 47 | 6. Juni 2014 (3:02) 

BioTOP-Report

 Business Location 

Business Location

Excellent Services for Berlin-Brandenburg

The Berlin-Brandenburg region harbors outstanding potential for technological development and cooperation in its 

high-density landscape of  scientific and research institutions. The high concentration of  international excellence 

here facilitates interdisciplinary exchange, making it easier to realize new, landmark developments. At the same 

time, the sheer number of  players can make it difficult to find the right partner. The region’s Inward Investment and 

Expansion team supports the healthcare and life sciences sectors with a full range of  services, including marketing 

activities at national and international trade shows. Our team has been in direct contact with the region’s companies 

and scientific institutions for many years and can provide quick access to the right contacts and potential partners.

In 2013, Berlin Partner for Business and Technology supported 

expansion projects and provided location services to 33 compa-

nies in Berlin, generating around 320 new jobs and a projected 

investment of  €63.9 million within the next three years. The list of  

companies includes Cell Medica, CBR Biotech Strategies, Amal 

Therapeutics and G&Life, an Italian company. 

In the same year, the Brandenburg Economic Development Board 

(ZAB) supported approx. 130 investment and innovation projects 

in the healthcare sector with a total investment volume of  around 

€27 m and the potential to create 220 new jobs. The successful 

location of  technology-based start-ups such as Glyco Universe, 

ai-ibiomics and medneo deserves special mention. The team 

at ZAB also supported the expansion investments of  resident 

companies co.don and Seramun. With the aim of  positioning 

the region’s companies in the global markets and presenting the 

Berlin-Brandenburg Healthcare Industries cluster – HealthCapi-

tal – as one of  Europe‘s leading healthcare sector locations, the 

region exhibited at four important international fairs in 2013.

As in previous years, we organized a Berlin-Brandenburg Night 

to mark the opening day of  the BIO conference and exhibition 

in Chicago. Once again, Bayer HealthCare was the lead sponsor. 

Accepting the invitation from HealthCapital and Bayer HealthCare, 

around 400 international guests from biotechnology and pharma-

ceutical companies attended the event.

To provide support in the areas of  internationalisation, technology 

transfer and regulatory affairs to companies and scientific institutes 

already located in Berlin and Brandenburg, we organized more 

than 30 conferences, workshops and networking events last year. 

The 2,000 accredited participants came from all over Germany. 

Berlin-Brandenburg is also a life sciences hot spot for internation-

al delegations. At the 2013 BIONNALE, our annual biotechnology 

conference, a group from Denmark presented its products and 

services and networked with representatives from regional com-

panies and scientific institutions.

In 2013, we kicked off  the first “Health Week” for the capital re-

gion. Companies and organisations from the healthcare industries 

took advantage of  the opportunity to showcase their prevention, 

diagnostics and therapy expertise and services. Over 90 com-

panies and institutions organized more than 300 public events in 

one week.

Dr. Rainer Knaus

Senior Vice President 

Cell Medica Ltd.

Cell Medica, a leading T-cell therapeutics company and pio-

neer in the field, acknowledges the importance of  the Ger-

man market and especially the excellent conditions in Berlin. 

The European commercial manufacturing facility within the 

Campus Berlin-Buch biotechnology park was designed and 

equipped to facilitate the high quality GMP-compliant produc-

tion of  patient-specific cell therapies for distribution across 

Europe. Here in Berlin, we have found an outstanding scien-

tific and industrial environment that allows us to attract highly 

educated, well-trained personnel who are keen to help shape 

this new era of  cell-based therapeutics.

Carolin Clement

Head of  Unit Biotech I Pharma 

Berlin Partner for Business and Technology

Phone [phone] 

[e-mail]

www.berlin-partner.de

Dr. Ute Hartmann

Head of  Department Healthcare Industry/ Life Sciences

Brandenburg Economic Development Board (ZAB)

Phone [phone]

[e-mail]

www.zab-brandenburg.de

---

Life Sciences.  

Living Research.  

Berlin. Brandenburg.

A vibrant network.

Berlin-Brandenburg is one of Europe´s leading locations for the 

Life Sciences. It is also an R&D capital that magnetically attracts 

the world´s top scientists. Here you´ll find attractive funding  

conditions, close linkages between business and science, the 

highest concentration of R&D in Europe, a dynamic startup scene 

and a multifaceted entrepreneurial environment made up of more 

than 500 pharmaceutical, biotech and medical technology  

companies. Come discover this one-of-a-kind landscape for  

scientists and entrepreneurs.

www.healthcapital.de

210x297_BIOTOP_Motiv_LifeScience_eng.indd   1

17.04.2014   15:35:53

---